ZA

Zuber Ahmed Dadulla Jagirdar

Director Director DIN 00250667
DIN 00250667 First appointment Apr 2006 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Apr 2006
Shareholding value β€’β€’β€’β€’ Premium profile

About Zuber Ahmed Dadulla Jagirdar

Data last updated:

Zuber Ahmed Dadulla Jagirdar was a Director at Integrated Medicines Private Limited (2006–2008). The company operates in Pharma.

DIN 00250667
Primary Designation Director
Industry Pharma
First Appointment 15 Apr 2006

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Integrated Medicines Private Limited U24239MH1991PTC063322
Director15 Apr 20061991Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Integrated Medicines Private Limited
Premium access

Shareholding and investment profile for Zuber Ahmed Dadulla Jagirdar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Zuber Ahmed Dadulla Jagirdar

Zuber Ahmed Dadulla Jagirdar was first appointed on 15 Apr 2006 as Director at Integrated Medicines Private Limited.

Zuber Ahmed Dadulla Jagirdar held 1 earlier board appointment: Integrated Medicines Private Limited (Director, 15 Apr 2006 to 20 Mar 2008).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available